Global Adoptive_Cellular_Immunotherapy Market 2020 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 58482
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 139
  • list Pharmaceuticals and Healthcare
Buy @ $3480
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.

Scope of the Report:
The global Adoptive_Cellular_Immunotherapy market is valued at xx million USD in 2020 and is expected to reach xx million USD by the end of 2026, growing at a CAGR of xx% between 2020 and 2026.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Adoptive_Cellular_Immunotherapy.
Europe also play important roles in global market, with market size of xx million USD in 2020 and will be xx million USD in 2026, with a CAGR of xx%.
This report studies the Adoptive_Cellular_Immunotherapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Adoptive_Cellular_Immunotherapy market by product type and applications/end industries.

Market Segment by Companies, this report covers
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Other

Market Segment by Applications, can be divided into
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Other
Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents
1 Adoptive_Cellular_Immunotherapy Market Overview
1.1 Product Overview and Scope of Adoptive_Cellular_Immunotherapy
1.2 Classification of Adoptive_Cellular_Immunotherapy by Types
1.2.1 Global Adoptive_Cellular_Immunotherapy Revenue Comparison by Types (2020-2026)
1.2.2 Global Adoptive_Cellular_Immunotherapy Revenue Market Share by Types in 2018
1.2.3 TIL
1.2.4 LAK
1.2.5 CAR-T
1.2.6 TCR-T
1.2.7 CIK
1.2.8 NK
1.2.9 DC
1.2.10 Other
1.3 Global Adoptive_Cellular_Immunotherapy Market by Application
1.3.1 Global Adoptive_Cellular_Immunotherapy Market Size and Market Share Comparison by Applications (2015-2026)
1.3.2 Hospital
1.3.3 Cancer Hospital
1.3.4 Centers for Disease Control and Prevention
1.3.5 Rehabilitation Center
1.3.6 Other
1.4 Global Adoptive_Cellular_Immunotherapy Market by Regions
1.4.1 Global Adoptive_Cellular_Immunotherapy Market Size (Million USD) Comparison by Regions (2015-2026)
1.4.1 North America (USA, Canada and Mexico) Adoptive_Cellular_Immunotherapy Status and Prospect (2015-2026)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Adoptive_Cellular_Immunotherapy Status and Prospect (2015-2026)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Adoptive_Cellular_Immunotherapy Status and Prospect (2015-2026)
1.4.4 South America (Brazil, Argentina, Colombia) Adoptive_Cellular_Immunotherapy Status and Prospect (2015-2026)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Adoptive_Cellular_Immunotherapy Status and Prospect (2015-2026)
1.5 Global Market Size of Adoptive_Cellular_Immunotherapy (2015-2026)
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Business Overview
2.1.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Autolus Therapeutics Plc
2.2.1 Business Overview
2.2.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Autolus Therapeutics Plc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Beijing Immunochina Medical Science & Technology Co Ltd
2.3.1 Business Overview
2.3.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bellicum Pharmaceuticals Inc
2.4.1 Business Overview
2.4.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bellicum Pharmaceuticals Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb Co
2.5.1 Business Overview
2.5.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Co Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 bluebird bio Inc
2.6.1 Business Overview
2.6.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 bluebird bio Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 CARsgen Therapeutics Ltd
2.7.1 Business Overview
2.7.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CARsgen Therapeutics Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Celgene Corp
2.8.1 Business Overview
2.8.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corp Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cell Medica Ltd
2.9.1 Business Overview
2.9.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cell Medica Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cellular Biomedicine Group Inc
2.10.1 Business Overview
2.10.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cellular Biomedicine Group Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Celularity Inc
2.11.1 Business Overview
2.11.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Celularity Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Celyad SA
2.12.1 Business Overview
2.12.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Celyad SA Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Daiichi Sankyo Co Ltd
2.13.1 Business Overview
2.13.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Daiichi Sankyo Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Fosun Pharmaceutical AG
2.14.1 Business Overview
2.14.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Fosun Pharmaceutical AG Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.15 Gilead Sciences Inc
2.15.1 Business Overview
2.15.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Gilead Sciences Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.16 Guangzhou Anjie Biomedical Technology Co Ltd
2.16.1 Business Overview
2.16.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hangzhou Converd Co Ltd
2.17.1 Business Overview
2.17.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Hangzhou Converd Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.18 Hebei Senlang Biotechnology Inc Ltd
2.18.1 Business Overview
2.18.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.19 HRAIN Biotechnology Co Ltd
2.19.1 Business Overview
2.19.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 HRAIN Biotechnology Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.20 Juno Therapeutics Inc
2.20.1 Business Overview
2.20.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Juno Therapeutics Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.21 Kite Pharma Inc
2.21.1 Business Overview
2.2.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Kite Pharma Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.22 Nanjing Legend Biotech Co Ltd
2.22.1 Business Overview
2.22.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Nanjing Legend Biotech Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.23 NantKwest Inc
2.23.1 Business Overview
2.23.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 NantKwest Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.24 Nkarta Inc
2.24.1 Business Overview
2.24.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Nkarta Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.25 Novartis AG
2.25.1 Business Overview
2.25.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Novartis AG Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.26 Ono Pharmaceutical Co Ltd
2.26.1 Business Overview
2.26.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Ono Pharmaceutical Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
2.27.1 Business Overview
2.27.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.28 Sorrento Therapeutics Inc
2.28.1 Business Overview
2.28.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Sorrento Therapeutics Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.29 Takara Bio Inc
2.29.1 Business Overview
2.29.2 Adoptive_Cellular_Immunotherapy Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 Takara Bio Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
3 Global Adoptive_Cellular_Immunotherapy Market Competition, by Players
3.1 Global Adoptive_Cellular_Immunotherapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Adoptive_Cellular_Immunotherapy Players Market Share
3.2.2 Top 10 Adoptive_Cellular_Immunotherapy Players Market Share
3.3 Market Competition Trend
4 Global Adoptive_Cellular_Immunotherapy Market Size by Regions
4.1 Global Adoptive_Cellular_Immunotherapy Revenue and Market Share by Regions
4.2 North America Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
4.3 Europe Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
4.5 South America Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
5 North America Adoptive_Cellular_Immunotherapy Revenue by Countries
5.1 North America Adoptive_Cellular_Immunotherapy Revenue by Countries (2014-2019)
5.2 USA Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
5.3 Canada Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
6 Europe Adoptive_Cellular_Immunotherapy Revenue by Countries
6.1 Europe Adoptive_Cellular_Immunotherapy Revenue by Countries (2014-2019)
6.2 Germany Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
6.3 UK Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
6.4 France Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
6.5 Russia Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
6.6 Italy Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Adoptive_Cellular_Immunotherapy Revenue by Countries
7.1 Asia-Pacific Adoptive_Cellular_Immunotherapy Revenue by Countries (2014-2019)
7.2 China Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
7.3 Japan Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
7.4 Korea Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
7.5 India Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
8 South America Adoptive_Cellular_Immunotherapy Revenue by Countries
8.1 South America Adoptive_Cellular_Immunotherapy Revenue by Countries (2014-2019)
8.2 Brazil Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Adoptive_Cellular_Immunotherapy by Countries
9.1 Middle East and Africa Adoptive_Cellular_Immunotherapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
9.3 UAE Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
10 Global Adoptive_Cellular_Immunotherapy Market Segment by Type
10.1 Global Adoptive_Cellular_Immunotherapy Revenue and Market Share by Type (2014-2019)
10.2 Global Adoptive_Cellular_Immunotherapy Market Forecast by Type (2020-2026)
10.3 TIL Revenue Growth Rate (2015-2026)
10.4 LAK Revenue Growth Rate (2015-2026)
10.5 CAR-T Revenue Growth Rate (2015-2026)
10.6 TCR-T Revenue Growth Rate (2015-2026)
10.7 CIK Revenue Growth Rate (2015-2026)
10.8 NK Revenue Growth Rate (2015-2026)
10.9 DC Revenue Growth Rate (2015-2026)
10.10 Other Revenue Growth Rate (2015-2026)
11 Global Adoptive_Cellular_Immunotherapy Market Segment by Application
11.1 Global Adoptive_Cellular_Immunotherapy Revenue Market Share by Application (2014-2019)
11.2 Adoptive_Cellular_Immunotherapy Market Forecast by Application (2020-2026)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Cancer Hospital Revenue Growth (2014-2019)
11.5 Centers for Disease Control and Prevention Revenue Growth (2014-2019)
11.6 Rehabilitation Center Revenue Growth (2014-2019)
11.7 Other Revenue Growth (2014-2019)
12 Global Adoptive_Cellular_Immunotherapy Market Size Forecast (2020-2026)
12.1 Global Adoptive_Cellular_Immunotherapy Market Size Forecast (2020-2026)
12.2 Global Adoptive_Cellular_Immunotherapy Market Forecast by Regions (2020-2026)
12.3 North America Adoptive_Cellular_Immunotherapy Revenue Market Forecast (2020-2026)
12.4 Europe Adoptive_Cellular_Immunotherapy Revenue Market Forecast (2020-2026)
12.5 Asia-Pacific Adoptive_Cellular_Immunotherapy Revenue Market Forecast (2020-2026)
12.6 South America Adoptive_Cellular_Immunotherapy Revenue Market Forecast (2020-2026)
12.7 Middle East and Africa Adoptive_Cellular_Immunotherapy Revenue Market Forecast (2020-2026)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Adoptive_Cellular_Immunotherapy Picture
Table Product Specifications of Adoptive_Cellular_Immunotherapy
Table Global Adoptive_Cellular_Immunotherapy and Revenue (Million USD) Market Split by Product Type
Figure Global Adoptive_Cellular_Immunotherapy Revenue Market Share by Types in 2018
Figure TIL Picture
Figure LAK Picture
Figure CAR-T Picture
Figure TCR-T Picture
Figure CIK Picture
Figure NK Picture
Figure DC Picture
Figure Other Picture
Table Global Adoptive_Cellular_Immunotherapy Revenue (Million USD) by Application (2015-2026)
Figure Adoptive_Cellular_Immunotherapy Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Cancer Hospital Picture
Figure Centers for Disease Control and Prevention Picture
Figure Rehabilitation Center Picture
Figure Other Picture
Table Global Market Adoptive_Cellular_Immunotherapy Revenue (Million USD) Comparison by Regions 2015-2026
Figure North America Adoptive_Cellular_Immunotherapy Revenue (Million USD) and Growth Rate (2015-2026)
Figure Europe Adoptive_Cellular_Immunotherapy Revenue (Million USD) and Growth Rate (2015-2026)
Figure Asia-Pacific Adoptive_Cellular_Immunotherapy Revenue (Million USD) and Growth Rate (2015-2026)
Figure South America Adoptive_Cellular_Immunotherapy Revenue (Million USD) and Growth Rate (2015-2026)
Figure Middle East and Africa Adoptive_Cellular_Immunotherapy Revenue (Million USD) and Growth Rate (2015-2026)
Figure Global Adoptive_Cellular_Immunotherapy Revenue (Million USD) and Growth Rate (2015-2026)
Table Amgen Inc Basic Information, Manufacturing Base and Competitors
Table Amgen Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table Amgen Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Autolus Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table Autolus Therapeutics Plc Adoptive_Cellular_Immunotherapy Type and Applications
Table Autolus Therapeutics Plc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Beijing Immunochina Medical Science & Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Bellicum Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table Bellicum Pharmaceuticals Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table Bellicum Pharmaceuticals Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Co Adoptive_Cellular_Immunotherapy Type and Applications
Table Bristol-Myers Squibb Co Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table bluebird bio Inc Basic Information, Manufacturing Base and Competitors
Table bluebird bio Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table bluebird bio Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table CARsgen Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table CARsgen Therapeutics Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table CARsgen Therapeutics Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Celgene Corp Basic Information, Manufacturing Base and Competitors
Table Celgene Corp Adoptive_Cellular_Immunotherapy Type and Applications
Table Celgene Corp Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Cell Medica Ltd Basic Information, Manufacturing Base and Competitors
Table Cell Medica Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table Cell Medica Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Cellular Biomedicine Group Inc Basic Information, Manufacturing Base and Competitors
Table Cellular Biomedicine Group Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table Cellular Biomedicine Group Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Celularity Inc Basic Information, Manufacturing Base and Competitors
Table Celularity Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table Celularity Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Celyad SA Basic Information, Manufacturing Base and Competitors
Table Celyad SA Adoptive_Cellular_Immunotherapy Type and Applications
Table Celyad SA Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Co Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table Daiichi Sankyo Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Fosun Pharmaceutical AG Basic Information, Manufacturing Base and Competitors
Table Fosun Pharmaceutical AG Adoptive_Cellular_Immunotherapy Type and Applications
Table Fosun Pharmaceutical AG Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table Gilead Sciences Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Guangzhou Anjie Biomedical Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Hangzhou Converd Co Ltd Basic Information, Manufacturing Base and Competitors
Table Hangzhou Converd Co Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table Hangzhou Converd Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Hebei Senlang Biotechnology Inc Ltd Basic Information, Manufacturing Base and Competitors
Table Hebei Senlang Biotechnology Inc Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table Hebei Senlang Biotechnology Inc Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table HRAIN Biotechnology Co Ltd Basic Information, Manufacturing Base and Competitors
Table HRAIN Biotechnology Co Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table HRAIN Biotechnology Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Juno Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Juno Therapeutics Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table Juno Therapeutics Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Kite Pharma Inc Basic Information, Manufacturing Base and Competitors
Table Kite Pharma Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table Kite Pharma Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Nanjing Legend Biotech Co Ltd Basic Information, Manufacturing Base and Competitors
Table Nanjing Legend Biotech Co Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table Nanjing Legend Biotech Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table NantKwest Inc Basic Information, Manufacturing Base and Competitors
Table NantKwest Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table NantKwest Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Nkarta Inc Basic Information, Manufacturing Base and Competitors
Table Nkarta Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table Nkarta Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Adoptive_Cellular_Immunotherapy Type and Applications
Table Novartis AG Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Ono Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table Ono Pharmaceutical Co Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table Ono Pharmaceutical Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive_Cellular_Immunotherapy Type and Applications
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Sorrento Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Sorrento Therapeutics Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table Sorrento Therapeutics Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Takara Bio Inc Basic Information, Manufacturing Base and Competitors
Table Takara Bio Inc Adoptive_Cellular_Immunotherapy Type and Applications
Table Takara Bio Inc Adoptive_Cellular_Immunotherapy Revenue, Gross Margin and Market Share (2018-2019)
Table Global Adoptive_Cellular_Immunotherapy Revenue (Million USD) by Players (2014-2019)
Table Global Adoptive_Cellular_Immunotherapy Revenue Share by Players (2014-2019)
Figure Global Adoptive_Cellular_Immunotherapy Revenue Share by Players in 2017
Figure Global Adoptive_Cellular_Immunotherapy Revenue Share by Players in 2018
Figure Global Top 5 Players Adoptive_Cellular_Immunotherapy Revenue Market Share in 2018
Figure Global Top 10 Players Adoptive_Cellular_Immunotherapy Revenue Market Share in 2018
Figure Global Adoptive_Cellular_Immunotherapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Adoptive_Cellular_Immunotherapy Revenue (Million USD) by Regions (2014-2019)
Table Global Adoptive_Cellular_Immunotherapy Revenue Market Share by Regions (2014-2019)
Figure Global Adoptive_Cellular_Immunotherapy Revenue Market Share by Regions (2014-2019)
Figure Global Adoptive_Cellular_Immunotherapy Revenue Market Share by Regions in 2018
Figure North America Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Europe Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure South America Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Table North America Adoptive_Cellular_Immunotherapy Revenue by Countries (2014-2019)
Table North America Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure North America Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure North America Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries in 2018
Figure USA Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Canada Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Mexico Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Table Europe Adoptive_Cellular_Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Europe Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries in 2018
Figure Germany Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure UK Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure France Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Russia Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Italy Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Adoptive_Cellular_Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries in 2018
Figure China Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Japan Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Korea Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure India Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Table South America Adoptive_Cellular_Immunotherapy Revenue by Countries (2014-2019)
Table South America Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure South America Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure South America Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries in 2018
Figure Brazil Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Argentina Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Colombia Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Adoptive_Cellular_Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Adoptive_Cellular_Immunotherapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure UAE Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Egypt Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Figure South Africa Adoptive_Cellular_Immunotherapy Revenue and Growth Rate (2014-2019)
Table Global Adoptive_Cellular_Immunotherapy Revenue (Million USD) by Type (2014-2019)
Table Global Adoptive_Cellular_Immunotherapy Revenue Share by Type (2014-2019)
Figure Global Adoptive_Cellular_Immunotherapy Revenue Share by Type (2014-2019)
Figure Global Adoptive_Cellular_Immunotherapy Revenue Share by Type in 2018
Table Global Adoptive_Cellular_Immunotherapy Revenue Forecast by Type (2019-2024)
Figure Global Adoptive_Cellular_Immunotherapy Market Share Forecast by Type (2019-2024)
Figure Global TIL Revenue Growth Rate (2014-2019)
Figure Global LAK Revenue Growth Rate (2014-2019)
Figure Global CAR-T Revenue Growth Rate (2014-2019)
Figure Global TCR-T Revenue Growth Rate (2014-2019)
Figure Global CIK Revenue Growth Rate (2014-2019)
Figure Global NK Revenue Growth Rate (2014-2019)
Figure Global DC Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Adoptive_Cellular_Immunotherapy Revenue by Application (2014-2019)
Table Global Adoptive_Cellular_Immunotherapy Revenue Share by Application (2014-2019)
Figure Global Adoptive_Cellular_Immunotherapy Revenue Share by Application (2014-2019)
Figure Global Adoptive_Cellular_Immunotherapy Revenue Share by Application in 2018
Table Global Adoptive_Cellular_Immunotherapy Revenue Forecast by Application (2019-2024)
Figure Global Adoptive_Cellular_Immunotherapy Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Cancer Hospital Revenue Growth Rate (2014-2019)
Figure Global Centers for Disease Control and Prevention Revenue Growth Rate (2014-2019)
Figure Global Rehabilitation Center Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Adoptive_Cellular_Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Adoptive_Cellular_Immunotherapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Adoptive_Cellular_Immunotherapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Adoptive_Cellular_Immunotherapy Revenue Market Forecast (2019-2024)
Figure Europe Adoptive_Cellular_Immunotherapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Adoptive_Cellular_Immunotherapy Revenue Market Forecast (2019-2024)
Figure South America Adoptive_Cellular_Immunotherapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Adoptive_Cellular_Immunotherapy Revenue Market Forecast (2019-2024)

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz